PDL BioPharma, Inc.PDLI announced that it has acquired a portion of the royalties on sales of AcelRx Pharmaceuticals Inc.’s ACRX Zalviso in the EU, Switzerland and Australia. We note that, AcelRx has a collaboration agreement with Grünenthal GmbH under